Modern neuroimaging techniques, by virtue of their non-invasive, multi-modal nature, have the potential to transform the clinical management of psychiatric and neurological disorders. However, despite their obvious promise, progress towards a personalised medicine framework has been slow, with limited clinical impact. For example, there are, as yet, no established methods that are able to predict the clinical progression of psychiatric disorders from a set of baseline measurements, despite the obvious benefits it would afford in terms of more informed choices about disease management and treatment.